Skip to main navigation Skip to search Skip to main content

Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Grants and Contracts Details

Description

Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
StatusFinished
Effective start/end date9/4/208/31/23

Funding

  • Atrium Health: $2.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.